samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PM Group Worldwide Ltd and The Datateam Media Group announce acquisition of Samedan Ltd

Samedan Ltd



PMGroup Worldwide Ltd and The Datateam Media Group are pleased and excited to announce the acquisition of pharmaceutical publishers Samedan Ltd.

The deal brings together three publishing powerhouses in the pharmaceutical and healthcare sector - with Samedan joining PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Group’s healthcare division.

The acquisition will see PMGroup take over a number of market-leading titles for industry professionals including Pharmafocus, Pharmafile, European Pharmaceutical Contractor (EPC), European Biopharmaceutical Review (EBR), International Clinical Trials (ICT), Pharmaceutical Manufacturing and Packing Sourcer (PMPS), Innovations in Pharmaceutical Technology (IPT), and all associated websites, including the influential pharmafile.com.

London-based Samedan Ltd has been producing a wide range of magazines for the global pharmaceutical arena since 1996, covering a wide range of hot topics including R&D, clinical trials, cutting-edge technology, manufacture, packaging, logistics, regulations, and industry insight.

With a wealth of respected titles ranging from research and clinical trials, manufacturing, packaging, marketing, communications and sales through to healthcare journals and best practice schemes, the new group spans the full cycle of the healthcare and pharmaceutical industry.

The expanded portfolio delivers a huge UK and global reach with millions of users, readers, followers and attendees.

As well as established titles like PME, PharmaTimes and Pharmafocus and digital products like PMLiVE, pharmafile.com and pharmatimes.com the union will allow all brands to expand their live, virtual and hybrid events and award schemes.

Gulia Selby, Managing Director of Samedan Ltd said “We are excited to build on Samedan Ltd’s more than 20 years of expertise in the pharmaceutical and healthcare sectors, and continue to grow with the support of PMGroup and Datateam.”

Managing Director of The Datateam Media Group, Parvez Kayani, stated he was absolutely delighted with the acquisition, and is very pleased to emerge from the recent pandemic with a strengthened team and a much expanded portfolio in the healthcare sector.

The Samedan portfolio will continue to be produced by the current team and the overall business will now be headed up by Karl Equi, Executive Director, PMGroup and Tara Lovegrove, Business Director, PMGroup.

Karl Equi commented: “We are really excited to welcome the Samedan team on board and look forward to building on the fantastic brands, titles and events we now have - as well as continuing to develop new projects across the expanded group”.

Tara Lovegrove added: “We are happy to be able to offer our clients an expanded portfolio of products and services and an audience for every message and brand”.

For more information about the expanded portfolio contact sales director Tara Lovegrove - tlovegrove@pmlive.com 

PMGroupWorldwide Ltd is a wholly owned subsidiary of The Datateam Media Group.
phone 02077243456
email info@samedanltd.com
web www.samedanltd.com/
email Suite E, 11 Bell Yard Mews, 175 Bermondsey Street
 
Print this page
Send to a friend
   
spacer
News and Press Releases

X-Chem Acquires ComInnex

WALTHAM, Mass.; Oct. 25, 2021 (Business Wire) – X-Chem, the pioneer of DNA-encoded library (DEL) technology and recognized leader in generating actionable results to drive small molecule drug discovery, today announced the acquisition of ComInnex, a leading European provider of synthetic chemistry services and novel chemical technologies to support early-stage drug discovery.
More info >>


White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement